Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/85648, first published .
Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine

Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine

Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine

Ayako Higuchi   1 , MSc ;   Yumiko Koi   2 , MD, PhD ;   Tomoaki Eto   1, 3 , MSc ;   Yuka Maeda   1 , BSc ;   Wakako Tajiri   2 , MD ;   Junji Kawasaki   2 , MD ;   Sayuri Akiyoshi   2 , MD, PhD ;   Hideki Ijichi   2 , MD, PhD ;   Yoshiaki Nakamura   2 , MD, PhD ;   Chinami Koga   2 , MD ;   Mototsugu Shimokawa   4 , PhD ;   Hiroaki Shimizu   1, 5 , BSc ;   Toshihiro Matsumoto   1 , BSc ;   Eriko Tokunaga   2 , MD, PhD

1 Department of Pharmacy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

2 Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

3 Department of Pharmacy, National Hospital Organization Kokura Medical Center, Kitakyushu, Japan

4 Department of Biostatistics, Yamaguchi University, Yamaguchi, Japan

5 Department of Pharmacy, National Sanatorium Kikuchi Keifuen, Koshi, Japan

Corresponding Author: